Cargando…
Prognostic role of EGR1 in breast cancer: a systematic review
EGR1 (early growth response 1) is dysregulated in many cancers and exhibits both tumor suppressor and promoter activities, making it an appealing target for cancer therapy. Here, we used a systematic multiomics analysis to review the expression of EGR1 and its role in regulating clinical outcomes in...
Autores principales: | Saha, Subbroto Kumar, Islam, S. M. Riazul, Saha, Tripti, Nishat, Afsana, Biswas, Polash Kumar, Gil, Minchan, Nkenyereye, Lewis, El-Sappagh, Shaker, Islam, Md. Saiful, Cho, Ssang-Goo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560464/ https://www.ncbi.nlm.nih.gov/pubmed/34488929 http://dx.doi.org/10.5483/BMBRep.2021.54.10.087 |
Ejemplares similares
-
High Expression of TTYH3 Is Related to Poor Clinical Outcomes in Human Gastric Cancer
por: Saha, Subbroto Kumar, et al.
Publicado: (2019) -
Systematic Multiomics Analysis of Alterations in C1QBP mRNA Expression and Relevance for Clinical Outcomes in Cancers
por: Saha, Subbroto Kumar, et al.
Publicado: (2019) -
PROM1 and PROM2 expression differentially modulates clinical prognosis of cancer: a multiomics analysis
por: Saha, Subbroto Kumar, et al.
Publicado: (2019) -
GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17
por: Saha, Subbroto Kumar, et al.
Publicado: (2020) -
G protein-coupled receptors in stem cell maintenance and somatic reprogramming to pluripotent or cancer stem cells
por: Choi, Hye Yeon, et al.
Publicado: (2015)